Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Oncology Center of Excellence

Oncology Center of Excellence

                        Who We Are - Oncology Center of Excellence
          Project Patient Voice


                        OCE Annual Reports
          Project Community Home
          About FDA
          FDA Organization
          Oncology Center of Excellence
          Oncology Cell and Gene TherapyOncology Center of Excellence Oncology Cell and Gene Therapy
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe Oncology Cell and Gene Therapy program focuses on clinical evaluations for, and helps to expedite development of, transformative cancer therapies based on cutting-edge technologies with curative potential. Examples include T-cells modified with chimeric antigen receptors (CAR-Ts) or with T-cell receptors with redirected specificity (TCR-Ts), and developed using technologies including gene-editing, e.g., clustered regularly interspaced short palindromic repeats (CRISPR) or transcription activator-like effector nucleases (TALEN); novel strategies in hematopoietic stem cell transplantation (HSCT); dendritic cells; adoptive T-cell therapies; tumor neoantigen-based personalized medicine (vaccine or cell therapy); natural killer cells; oncolytic bacteria and viruses; therapeutic cancer vaccines; therapies that modulate the microbiome; and combinations of these therapeutics with hematopoietic stem cell transplantation, checkpoint inhibitors, chemotherapies, radiation and other agents.

The program leverages the combined skills of FDA clinical oncology review staff and regulatory scientists from other disciplines to address unique challenges in the clinical trial design and development of such products. These may include potentially transformative products that are manufactured from the patient’s own cells (i.e., autologous products).  The clinical development of such autologous products has to consider the lag time required to manufacture the final product from the patient’s cells.  Other considerations in the development of cell and gene therapies include their unique pharmacodynamics and / or pharmacokinetics, development of biomarkers to determine which patients are eligible for any specific clinical trial, development of biomarkers to monitor the response to the therapy, the distinctive safety and activity profiles of live microorganisms and cell products that are capable of renewing and proliferating, and long-term follow-up of patients receiving genetically modified products.

As one of the programs within the Oncology Center of Excellence (OCE), the Oncology Cell and Gene Therapy program emphasizes emerging oncology science to achieve excellence in medical product regulation.  Using this scientific base, the Oncology Cell and Gene Therapy program collaborates with academia, industry, patient advocacy groups, professional societies, and other international regulators to advance the OCE mission to accelerate the development and streamline the evaluation process of safe and effective products for patients.

                                                                                  Content current as of:
      02/06/2018Oncology Center of Excellence

          
                        Who We Are - Oncology Center of Excellence
          Project Patient Voice


                        OCE Annual Reports
          Project Community
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop